Heliogen - HLGN Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Heliogen in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" HLGN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLGN, but not buy additional shares or sell existing shares.
View HLGN analyst ratings or view top-rated stocks.

1 brokerages have issued 12 month price targets for Heliogen's shares. Their HLGN share price forecasts range from $2.00 to $2.00. On average, they anticipate the company's stock price to reach $2.00 in the next twelve months. This suggests a possible upside of 200.6% from the stock's current price.
View analysts price targets for HLGN or view top-rated stocks among Wall Street analysts.

Heliogen's stock was trading at $0.6982 at the beginning of the year. Since then, HLGN stock has decreased by 4.7% and is now trading at $0.6654.
View the best growth stocks for 2023 here.

Heliogen saw a decrease in short interest in the month of December. As of December 30th, there was short interest totaling 6,240,000 shares, a decrease of 17.1% from the December 15th total of 7,530,000 shares. Based on an average daily volume of 1,820,000 shares, the days-to-cover ratio is currently 3.4 days. Approximately 4.5% of the shares of the company are sold short.
View Heliogen's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, March 27th 2023.
View our HLGN earnings forecast.

Heliogen, Inc. (NYSE:HLGN) released its earnings results on Monday, November, 7th. The company reported ($0.14) EPS for the quarter. The business earned $3.10 million during the quarter. Heliogen had a negative trailing twelve-month return on equity of 87.56% and a negative net margin of 1,091.32%.

Heliogen updated its FY 2022 earnings guidance on Tuesday, November, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $12.00 million-$14.00 million, compared to the consensus revenue estimate of $21.72 million.

Heliogen trades on the New York Stock Exchange (NYSE) under the ticker symbol "HLGN."

Heliogen's stock is owned by many different institutional and retail investors. Top institutional investors include Bank of Montreal Can (0.04%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Andrew Alan Lambert, Dakin Sloss, Neotribe Partners I, Llc and William Gross.
View institutional ownership trends.

Shares of HLGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HLGN stock can currently be purchased for approximately $0.67.

Heliogen (NYSE:HLGN) has a market capitalization of $126.66 million and generates $8.80 million in revenue each year.

The company employs 150 workers across the globe.

Heliogen's mailing address is 125 TOWNPARK DRIVE SUITE 300, KENNESAW GA, 30144. The official website for the company is www.athena1.com. The company can be reached via phone at 626-720-4530 or via email at cherita@athena1.com.